T
Teladoc Health, Inc. (TDOC)
NYQ – Real Time Price. Currency in USD
5.14
-0.38 (-6.88%)
At close: Mar 27, 2026, 4:00 PM EDT
5.13
-0.01 (-0.19%)
After-hours: Mar 27, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
NYQ – Real Time Price. Currency in USD
5.14
-0.38 (-6.88%)
At close: Mar 27, 2026, 4:00 PM EDT
5.13
-0.01 (-0.19%)
After-hours: Mar 27, 2026, 7:58 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.69 | 2.19 | 10 | |
| Quick ratio | 2.59 | 1.96 | 10 | |
| Debt to Equity | 0.75 | 1.16 | 7.0 | |
| Debt to Assets | 0.34 | 2.94 | 6.0 | |
| Interest coverage | -5.45 | -28.30 | 1.0 | |
| Weighted average score | 6.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2.41B | 2.60B | 2.57B | 2.53B | 2.53B |
| Gross Profit | 1.41B | 1.51B | 1.44B | 1.39B | 1.39B |
| Operating Income | -227M | -211M | -209M | -163M | -163M |
| Net Income | -13.66B | -220M | -1B | -200M | -200M |
| EBITDA | 43M | 141M | 174M | 213M | 213M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -2.47 | 35.63 | 5.5 |
| Next quarter | -1.12 | -19.36 | 1.0 |
| Current year | -0.74 | 21.39 | 5.5 |
| Next year | 1.18 | 17.92 | 6.0 |
| Weighted average score | 4.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 2.53 | 49.21 | 50 | -8.34 | 6.3 |
| Y/Y | 0.28 | 48.06 | 50 | 6.71 | 6.8 |
| 3y average | 1.78 | -58.64 | -53.01 | 26.32 | 3.8 |
| 5y average | 21.91 | -649.97 | -621.76 | 98.9 | 5.5 |
| Weighted average score | 5.6 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $1.0B significantly exceeds cash reserves ($781.1M), raising financial stability concerns
Total current assets $1.1B exceed Total current liabilities $404.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.8) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-5.4x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $85.1M, supporting its financial health